Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Verona Pharma’s $650 Million Financing Round
OMERS Life Sciences’ $200 Million Acquisition of Portion of Global Royalties on MAVYRE
Ballard Spahr represented OMERS Life Sciences on the deal. Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral...